JIYA ACQUISITION CORP's ticker is JYAC and the CUSIP is 47760M102. A total of 55 filers reported holding JIYA ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,246,000 | +0.8% | 125,000 | 0.0% | 0.04% | -4.3% |
Q2 2022 | $1,236,000 | +0.6% | 125,000 | 0.0% | 0.05% | +6.8% |
Q1 2022 | $1,229,000 | +0.7% | 125,000 | 0.0% | 0.04% | +46.7% |
Q4 2021 | $1,221,000 | +0.2% | 125,000 | 0.0% | 0.03% | -33.3% |
Q3 2021 | $1,219,000 | -1.9% | 125,000 | 0.0% | 0.04% | +25.0% |
Q2 2021 | $1,243,000 | – | 125,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 562,500 | $5,524,000 | 2.58% |
Samsara BioCapital, LLC | 507,041 | $4,984,000 | 1.26% |
Altium Capital Management LP | 200,000 | $1,966,000 | 0.66% |
Bain Capital Life Sciences Investors, LLC | 300,000 | $2,949,000 | 0.29% |
GLAZER CAPITAL, LLC | 1,003,386 | $9,853,000 | 0.28% |
Integrity Capital Management (HK) Ltd | 5,000 | $49,000 | 0.25% |
Spartan Fund Management Inc. | 100,000 | $1,228,000 | 0.20% |
Context Capital Management, LLC | 300,000 | $2,949,000 | 0.19% |
PFM Health Sciences, LP | 464,103 | $4,562,000 | 0.17% |
EcoR1 Capital, LLC | 500,000 | $4,915,000 | 0.15% |